Guideline-Based AI Segmentation
The collaboration authorizes Medron Medical Systems to distribute MVision AI’s Contour+, Guide and Verify throughout Canada.
HELSINKI, FINLAND, January 24, 2024 /EINPresswire.com/ — MVision AI, a premier software service provider of GBS
(Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL) approval from Health Canada.
Ronald Wallace, President of Medron Medical Systems Inc., commented on the evolving landscape of radiation oncology, stating, “Innovation and the introduction of new modalities in radiation oncology have changed the landscape in how Radiation Therapy is delivered. The introduction of artificial intelligence (AI) in treatment planning is the beginning of a new era that will assist clinicians to offer unprecedented precision and personalized care to patients, marking a significant leap forward in advancing the field of radiation oncology.”
With a shared commitment to enhancing oncology departments’ workflow, both companies aim to deliver the world’s first comprehensive solution for AI radiotherapy contouring, comprising three innovative products – Contour+, Guide, and Verify.
Stewart Pegrum, Vice President Global Sales at MVision AI, highlighted the company’s rapid expansion and expressed excitement about initiating this partnership with Medron Medical Systems for Canadian hospitals. He stated, “We are already assisting our customers to fulfill their desires to deliver same day treatment for their patients. I am delighted that in collaboration with Medron, we can now offer this service to the patients of Canada.”
For additional inquiries on Medron Medical System:
Medron Medical Systems Inc. is a Canadian company that specializes in providing quality products and services to healthcare professionals, particularly in the fields of Radiological Imaging, Nuclear Medicine, Radiation Oncology, and Medical Physics. The company is a leader in the Canadian healthcare sector, offering a range of medical equipment and solutions to healthcare facilities throughout the country.
Website: medron.ca
Email: [email protected]
Tel: +1 613-769-3302
Learn more about incorporating MVision AI’s GBS solution:
MVision AI is your trusted partner in healthcare innovation. We are a team of experienced professionals committed to revolutionizing the cancer care industry through the application of cutting-edge AI technology. At MVision AI, we understand the challenges faced by healthcare providers in delivering accurate, timely, and efficient cancer care to patients. That’s why we are developing a suite of AI-powered solutions that can help streamline radiation therapy workflows, enable treatment quality and lead to standardization.
MVision AI Oy
[email protected]
Alena Kruhlova
Visit us on social media:
Facebook
Twitter
LinkedIn
Contour+ Guideline-Based AI Segmentation | New launch | V 1.2.4
You just read:
EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.
Article originally published on www.einpresswire.com as MVision AI Announces The First Health Canada Medical Device License and Partnership with Medron Medical Systems
The post MVision AI Announces The First Health Canada Medical Device License and Partnership with Medron Medical Systems first appeared on Social Gov.
originally published at Global News - Social Gov